Antisense oligonucleotides: A personalized treatment approach for rare diseases
PHG Foundation - 07-Aug-2024Breakthrough for the rarest of rare genetic diseases that affect only a few patients
Join the club for FREE to access the whole archive and other member benefits.
Some medicine may work better for you - or not work at all. Efficacy of most drugs is remarkably poor - and that's before taking into account pharmaceutical companies only publish positive studies. Across a broad population, some drugs struggle to beat the efficacy of a placebo but may still inflict detrimental side effects.
We're finding more and more that some drugs work better for for people with certain characteristics in their DNA and even gene expression, as well as broader factors such as sex and health. Today, a doctor has to prescribe one drug, wait to see if it works, and then prescribe another one and another one until the most effective drug is found (no fault of the doctor - they have no way of knowing the best match). Soon they will be able to take a one drop of blood, perform an instant analysis, and select the best drug for you. And beyond that, rather than selecting the best matching drug for you, medicines may be designed for you exact condition and tailored perfectly to your individual body.
Breakthrough for the rarest of rare genetic diseases that affect only a few patients
Programmable mRNA tech promise precise & safe treatment for disease and age-related conditions
Fewer doses, better taste & improved adherence for rare diseases and beyond
Almost 4 million differences might be linked to disease risk, leading to targeted treatments
Click on resource name for more details.
17-Oct-2024
Congress that addresses healthy ageing and medical longevity (Alicante, Spain)
Why the Future of Medicine Is Personalized, Predictive, Data-Rich, and in Your Hands, written by Leroy Hood and Nathan Price
Applying Artificial General Intelligence to deliver decentralised precision health and predictive medicine
Global leader in digital therapeutics that combines the power of AI with wearables data to enable personalized care
Specialist biotech company developing 3D printing technology for pharmaceuticals and medical devices.
Algocyte platform uses algorithmic inverse problem solving to aid clinicians in their diagnosis
Adrian reviews a range of finalists trying to track cancer, blood oxygenation, retinal scans, and cardiac health